SundrugLtd Management
Management criteria checks 3/4
SundrugLtd's CEO is Hiroshi Sadakata, appointed in Apr 2022, has a tenure of 2.67 years. total yearly compensation is ¥165.00M, comprised of 13.9% salary and 86.1% bonuses, including company stock and options. directly owns 0.028% of the company’s shares, worth ¥129.74M. The average tenure of the management team and the board of directors is 16.5 years and 7 years respectively.
Key information
Hiroshi Sadakata
Chief executive officer
JP¥165.0m
Total compensation
| CEO salary percentage | 13.9% |
| CEO tenure | 2.7yrs |
| CEO ownership | 0.03% |
| Management average tenure | 16.5yrs |
| Board average tenure | 7yrs |
Recent management updates
Recent updates
SundrugLtd's (TSE:9989) Dividend Will Be ¥65.00
Dec 11
Is SundrugLtd (TSE:9989) Using Too Much Debt?
Dec 09Here's Why We Think SundrugLtd (TSE:9989) Is Well Worth Watching
Nov 18Investors Could Be Concerned With SundrugLtd's (TSE:9989) Returns On Capital
Nov 05Sundrug Co.,Ltd.'s (TSE:9989) Intrinsic Value Is Potentially 31% Above Its Share Price
Sep 25Sundrug Co.,Ltd.'s (TSE:9989) Business Is Yet to Catch Up With Its Share Price
Sep 11SundrugLtd's (TSE:9989) Upcoming Dividend Will Be Larger Than Last Year's
Aug 29SundrugLtd (TSE:9989) Will Pay A Larger Dividend Than Last Year At ¥65.00
Jul 26SundrugLtd (TSE:9989) Will Pay A Larger Dividend Than Last Year At ¥65.00
Jul 12Analyst Estimates: Here's What Brokers Think Of Sundrug Co.,Ltd. (TSE:9989) After Its Yearly Report
Jun 28SundrugLtd (TSE:9989) Ticks All The Boxes When It Comes To Earnings Growth
Jun 06Sundrug Co.,Ltd.'s (TSE:9989) Share Price Not Quite Adding Up
May 11Be Wary Of SundrugLtd (TSE:9989) And Its Returns On Capital
Apr 10SundrugLtd (TSE:9989) Will Pay A Dividend Of ¥57.00
Mar 11CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | JP¥29b |
| Jun 30 2024 | n/a | n/a | JP¥30b |
| Mar 31 2024 | JP¥165m | JP¥23m | JP¥29b |
Compensation vs Market: Hiroshi's total compensation ($USD1.05M) is about average for companies of similar size in the JP market ($USD914.37K).
Compensation vs Earnings: Insufficient data to compare Hiroshi's compensation with company performance.
CEO
Hiroshi Sadakata (54 yo)
2.7yrs
Tenure
JP¥165,000,000
Compensation
Mr. Sadakata Hiroshi serves as President at Sundrug Co.,Ltd. He has been Vice President and Representative Director, DIREX Corporation since December 2009. Mr. Hiroshi served as a General Manager of Operat...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Representative Director | 2.7yrs | JP¥165.00m | 0.028% ¥ 129.7m | |
| Chief of Office of President & GM of Sales Department | 16.5yrs | no data | no data | |
| GM of Store Development Department & Director | 19.7yrs | no data | 0.021% ¥ 98.3m |
16.5yrs
Average Tenure
59yo
Average Age
Experienced Management: 9989's management team is seasoned and experienced (16.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Representative Director | 16.5yrs | JP¥165.00m | 0.028% ¥ 129.7m | |
| GM of Store Development Department & Director | 14.5yrs | no data | 0.021% ¥ 98.3m | |
| External Independent Director | 6.5yrs | no data | no data | |
| External Independent Director | 4.5yrs | no data | no data | |
| Chairman | 23.5yrs | no data | 2.66% ¥ 12.2b | |
| Director | 7.5yrs | no data | 1.88% ¥ 8.7b | |
| External Corporate Auditor | 2.5yrs | no data | no data | |
| External Corporate Auditor | 5.5yrs | no data | no data |
7.0yrs
Average Tenure
61yo
Average Age
Experienced Board: 9989's board of directors are considered experienced (7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 18:00 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sundrug Co.,Ltd. is covered by 17 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Daisuke Matsumoto | Barclays |
| Arashi Nishizawa | BofA Global Research |
| Mayumi Ogino | Citigroup Inc |